Selected Grants
Regulation of Macrophage-Mediated Neovascular Remodeling in Neovascular AMD
ResearchPrincipal Investigator · Awarded by BrightFocus Foundation · 2021 - 2023SPIAM-202 - Age-Related Macular Degeneration with Geographic Atrophy
Clinical TrialPrincipal Investigator · Awarded by Stealth BioTherapeutics · 2019 - 2023An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects with Intermediate Age-Related Macular Degeneration
Clinical TrialCore PI · Awarded by Stealth BioTherapeutics · 2016 - 2022Handheld Confocal Scanning Laser Ophthalmoscope for Remote Screening of Diabetic Retinopathy
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2022PAN-01-102 - Multicenter Phase I/II Study to Evaluate Safety and Tolerability of Pan-90806 Eye Drops Suspension in Treatment-Naive Participants with Neovascular Age-Related Macular Degeneration (AMD)
Clinical TrialPrincipal Investigator · Awarded by PanOptica · 2018 - 2020Macrophages and Treatment-Resistant NVAMD
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2019Novel Small Molecule Macrophage Inhibitors for the Treatment of Retinal Diseases
ResearchPrincipal Investigator · Awarded by Eyedesis Biosciences LLC · 2017 - 2018Computer Aided Classification of Diabetic Macular Edema
ResearchCollaborator · Awarded by National Institutes of Health · 2012 - 2018Macrophages Drive Neovascular Remodeling in NVAMD
ResearchPrincipal Investigator · Awarded by BrightFocus Foundation · 2014 - 2016NEI Mentored Clinical Scientist Development Program Award (K12)
ResearchScholar · Awarded by National Institutes of Health · 2004 - 2016External Relationships
- Astellas Pharma Inc.
- Eclipse Life Sciences
- Iveric Bio
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.